bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) Special 510(k) clearance and CLIA-waiver (Clinical Laboratory Improvement Amendments).
Alliance for Multispecialty Research (AMR), a leading clinical research site company, and Waccamaw Dermatology, renowned for its comprehensive, specialized dermatological care as one of the largest physician-owned and led dermatology practices in the Carolinas, today announced a strategic partnership that expands access to clinical trials in the Carolinas.
Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer’s disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition’s disparate attack.
The first of its kind at an academic institution, the facility gives experts the capability to put live bacteria into capsules that can be administered safely to patients in clinical trials.
An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
JMIR Publications invites submissions to a new theme issue titled “Artificial Intelligence in Oncology” in its premier open access journal JMIR Bioinformatics and Biotechnology indexed in PubMed Central and PubMed, SCOPUS, Sherpa/Romeo, DOAJ and EBSCO/EBSCO Essentials.
Mayo Clinic announces a groundbreaking achievement in organ transplantation, offering hope to thousands who have lost their ability to speak, swallow and breathe on their own due to diminished function or loss of their larynx. A multidisciplinary team of doctors in Arizona performed the third known total larynx transplant in the U.S.
A major new grant will fund a study enrolling thousands of people from the time they schedule a mental health appointment, and gather data that could form the basis for precisely targeted treatment in future.
In collaboration with the company Pleural Dynamics, researchers at the UNC School of Medicine are the first to use a fully implantable automatic effusion shunt with no external catheters or expensive drainage canisters to provide an innovative new option for patients who struggle with chronic fluid collection.
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
"North American Cancer Center Clinical Research Capacity and Benchmarking in the Post-Pandemic Era" was published July 1 in JCO Oncology Practice, an American Society of Clinical Oncology (ASCO) Journal.
In support of the third annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is joining the COPD Foundation and several global organizations to raise awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.
• 97% of HER2+, early-stage patients treated with trastuzumab emtansine (T-DM1) were free of cancer recurrence five years after treatment • Prognostic test (HER2DX) shown helpful in identifying patients at greatest risk for recurrence
University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility’s grand opening in Hewitt Hall’s basement on the UC Irvine campus. Although the highly sterile environment remains off-limits for tours, the gala highlighted its importance to the campus, the UC system and the local community.
NCCN shares new data on continued high prevalence for cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.
These clinical trial results point to the first safe and effective use of immunotherapy for patients with microsatellite stable colorectal cancer, the most common subtype of the disease. The encouraging results of this phase I trial have prompted Dana-Farber investigators to move forward with a phase III trial of this immunotherapy combination.
Patients with moderate to severe treatment-resistant depression (TRD) might have better symptom relief from ketamine infusions than from electroconvulsive therapy (ECT), but those with severe TRD could benefit more from ECT early in treatment, an analysis led by a UT Southwestern Medical Center researcher shows. The findings, published in JAMA Network Open, are the first to identify characteristics that distinguish which treatments might benefit TRD patients more.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right